baber/WOPTO huggingface dataset:
Patent NZ-239803-A (NZ)
Title: Knife sharpener: sharpening action in one direction of blade movement
Inventor: WILLIAMS DAVID MARK
IPC: B24D15/08
Filed: 1991-09-16
Abstract: A blade sharpener of the kind having a pair of overlapping plates (8) which are relatively arranged to form a vee shaped sharpening recess (10) between them. Each of the opposite sloping sides of that recess (10) is formed by an operative edge (9) of a respective one of the two plates (8), and each of those edges (9) extends between a front face (12) and a back face (14) of the respective plate (8). A relatively sharp corner (13) is formed between each operative edge (9) and the back face (14) of the respective plate (8), and a relatively blunt, e.g. rounded, corner (11) is formed between each operative edge (9) and the front face (12) of the respective plate (8). The plates (8) may be mounted on a member (6) which can pivot between a position at which the plates (8) tilt forward and a position at which the plates (8) tilt back. Spring means (27,28) may be operative to engage the back edge of a blade located in the recess (10) so as to press the cutting edge of the blade against the plates (8). The arrangement is such that longitudinal movement of a blade through the recess (10) in a direction towards the plate front faces (12), causes the sharp edges (13) of the plates (8) to be operative to sharpen the cutting edge of the blade, whereas in the reverse direction of the blade the blunt edges (11) come into contact with the blade cutting edge so that sharpening of that edge does not occur. <IMAGE>
Patent NZ-254656-A (NZ)
Title: Tricyclic benzazepine derivatives; preparation and pharmaceutical compositions
Inventor: WARSHAWSKY ALAN M
IPC: A61K31/55
Filed: 1993-07-23
Abstract: The present invention relates to novel 2-substitited indane-2-mercaptoacetylamide tricyclic derivatives which are useful as inhibitors of Enkephalise.
Patent NZ-254662-A (NZ)
Title: Bis-n-substituted staurosporine and k-252a derivatives
Inventor: LEWIS MICHAEL
IPC: A61K31/553
Filed: 1993-07-26
Abstract: Derivatives of K-252a are useful for treating Parkinson's disease.
Patent NZ-291750-A (NZ)
Title: Analogues of haemophilus influenzae hin47 protein with reduced protease activity
Inventor: LOOSMORE SHEENA M
IPC: C12N15/31
Filed: 1995-07-21
Abstract: An isolated and purified analog of Haemophilus influenza Hin47 protein has a decreased protease activity which is less than about 10% of that of natural Hin47 protein and preferably substantially the same immunogenic properties as natural Hin47 protein. An isolated and purified nucleic acid molecule encoding the Hin47 analog may be provided in a recombinant plasmid which may be introduced into a cell which is grown to produce the Hin47 analog. Immunogenic compositions comprising the Hin47 analog and the encoding nucleic acid may be formulated as vaccines for in vivo administration to a host, including a human, to confer protection against diseases caused by a bacterial pathogen, including Haemophilus species, such as Haemophilus influenzae, that produces Hin47 protein or a protein capable of inducing antibodies in the host specifically reactive with Hin47 protein. The Hin47 analog and the encoding nucleic acid also may be employed in diagnostic applications.
Patent NZ-295900-A (NZ)
Title: Control room radio access to distributed field devices
Inventor: TAPPERSON GARY
IPC: G05B15/02
Filed: 1995-10-20
Abstract: An apparatus for accessing field devices in a distributed control system provides non-redundant secondary access to a plurality of field devices that are controlled by a control room. An apparatus also provides redundant wireless to access field devices in a distributed control system having primary access to the field devices provided by hard-wired media that couples the field devices to the control room. The field devices are coupled to a Fieldbus control network. In a first embodiment, each field device is provided with a wireless Fieldbus port that is accessible by a wireless handheld unit or wireless terminal. In a second embodiment, each Fieldbus control network is provided with a field module having a wireless Fieldbus port that allows all devices connected to the Fieldbus control network to be accessed by a wireless handheld unit or a wireless terminal. In a third embodiment, an H2-to-H1 Fieldbus bridge (which may service a plurality of H1 control networks) is provided with a wireless Fieldbus port that allows all Fieldbus devices connected to H1 control networks serviced by the H2-to-H1 bridge to be access by a wireless handheld unit of a wireless terminal. In a fourth embodiment, a bridge/converter provides an interface between older analog control room components and newer Fieldbus field devices.
Patent NZ-299913-A (NZ)
Title: Treatment of cancer using polypeptide bombesin/GRP antagonists
Inventor: SCHALLY ANDREW VICTOR
IPC: A61K38/08
Filed: 1994-03-07
Abstract: The pseudopeptides of formula (I) possess antagonist properties against bombesin or bombesin-related peptides (such as gastrin releasing peptide or Neuromdin C). The antagonists can be used in a medicament to treat cancer. (I) X-A1-A2-Trp-Ala-Val-Gly-His-Leu-psi-A9-Q Wherein; X is hydrogen, or a single bond linking the alpha amino group of A1 to the gamma carboxyl moiety on the 3-propionyl moiety of A2 when A2 is Glu, or a group of formula R1CO-, wherein R1 is selected from the groups consisting of: a) hydrogen, C1-10alkyl, phenyl or phenyl-C1-10-alkyl, p-Hl-phenyl, p-Hl-phenyl-C1-10-alkyl, naphthyl, naphthyl-C1-10-alkyl, indolyl, indolyl-C1-10-alkyl, pyridyl, pyridyl-C1-10-alkyl, thienyl, thienyl-C1-10-alkyl, cyclohexyl or cyclohexyl-C1-10-alkyl, where Hl=F, Cl, Br, OH, CH3 or OCH3; b) N(R2)(R3)-, wherein R2 is hydrogen, C1-10alkyl, phenyl or phenyl-C1-10-alkyl, and R3 is hydrogen or C1-10alkyl; c) R4O, wherein R4 is C1-10alkyl, phenyl or phenyl-C1-10-alkyl; A1 is a D- or L-amino acid residue selected from the group consisting of Phe, p-Hl-Phe, pGlu, Nal, Pal, Tpi, unsubstituted Trp or Trp substituted in the benzene ring by one or more members selected from the group consisting of F, Cl, Br, NH2 or C1-3alkyl; or A1 is a peptide bond linking the acyl moiety of R1CO- to the alpha amino moiety of A2, provided X=R1CO; A2 is Gln, Glu[-], Glu(Y) or His, wherein, when X is a single bond and A2 is Glu[-], [-] is a single bond linking the alpha amino group of A1 with the gamma carboxyl group of the 3-propionyl moiety of A2; Y is -OR5 or -N(R6)(R7),  wherein R5 is hydrogen, C1-3alkyl or phenyl; R6 is hydrogen or C1-3alkyl; and R7 is hydrogen, C1-3alkyl or -NHCONH2; Leu-psi is a reduced form of Leu, wherein the C=O moiety of Leu is replaced with -CH2- such that there is a pseudopeptide bond of this -CH2- moiety with the alpha amino moiety of the adjacent A9 residue;  A9 is Tac, MTac, or DMTac; and Q is NH2 or OQ1, where Q1 is hydrogen, C1-10alkyl, phenyl or phenyl-C1-10-alkyl.
Patent NZ-306316-A (NZ)
Title: use of lipoprotein and a type 2T independent antigen to induce an immune response to the antigen
Inventor: SNAPPER CLIFFORD M
IPC: A61P37/00
Filed: 1996-04-16
Abstract: A method of inducing or enhancing an immune response to polysaccharides or other T cell-independent antigen by the co-administration of the antigen with bacterial lipoproteins (including covalent attachment of the antigen and lipoproteins). In a preferred embodiment, the lipoprotein is lipoprotein D.
Patent NZ-315658-A (NZ)
Title: Striking ignition circuit for a high-pressure gas discharge lamp connectable to an a.c voltage source
Inventor: ARBINGER KAI
IPC: H05B41/04
Filed: 1996-08-01
Abstract: A striking circuit for a high-pressure discharge lamp (4) connected via a choke (3) to an a.c. voltage source and with a pulse transformer (5), the secondary winding (6) of which is fitted between the choke (3) and the lamp (4) and the primary winding (8) of which, with a switching component (9), forms a series circuit which in turn is connected in parallel to a pulse capacitor, in which a controllable switch (10) is connected in series with the parallel circuit of the pulse capacitor (7) on the one hand and the primary winding (8) and the switching component (9) on the other, said switch (10) being actuated on the occurrence of a striking pulse for the high-pressure gas discharge lamp (4) in such a way that the settlement of the oscillating circuit consisting of the pulse capacitor (7), the primary winding (8) and the switching component (9) or the rapid recovery of the switching component (9) is ensured. It is thus possible to obtain a short striking pulse sequence with a large number of striking pulses, thus ensuring that the lamp is reliably struck.
Patent NZ-330976-A (NZ)
Title: Data transmission using carrierless qam (quadrature amplitude modulation)
Inventor: COOK JOHN WOLSEY
IPC: H04L7/04
Filed: 1997-03-11
Abstract: The specification describes how carrierless signals of first and second channels pass via filters having quadrature responses and are then added for transmission. A receiver uses adaptive filters (4, 5) which also need quadrature responses to separate the channels effectively. To accommodate misconvergence of the filters giving rise to (a) inverted responses, (b) differential delays, (c) similar or identical responses and/or (d) transposed responses, and hence incorrect decoding: (a) the transmitter and receiver may employ differential coding (25-32) in each channel, (b) the receiver may calculate (33) the group delay of its filters and correct any error, (c) the receiver may compare (34) the filtered signals and if similar replace one filter response with a quadrature response calculated (39) from the other and/or (d) the receiver may respond to a failure to recognize (43, 44) expected synchronization words by transposing (45, 46) the responses of the filters.
Patent NZ-333975-A (NZ)
Title: Recombinant swinepox virus
Inventor: COCHRAN MARK D
IPC: C07K14/135
Filed: 1997-07-25
Abstract: The application provides a recombinant swinepox virus comprising a foreign DNA inserted into a swinepox virus genome, wherein the foreign DNA is inserted into a) an AccI site within a region corresponding to a 3.2 Kb HindIII to BglII subfragment of the HindII M fragment and b) b) an EcoRI site within a region corresponding to a 3.2 Kb subfragment of the HindIII K fragment which contains both a HindIII and EcoRI site, of the swinepox virus genome and is capable of being expressed in a host cell into which the virus is introduced. The application further provides vaccines and methods of immunization of the recombinant swinepox virus.
Patent NZ-334595-A (NZ)
Title: Peptide prodrugs containing an alpha-hydroxyacid linker that have increased stability against enzymatic cleavage
Inventor: LARSEN BJARNE DUE
IPC: A61K47/48
Filed: 1997-09-09
Abstract: Peptide prodrugs of the general formula (I): X-L-Z, wherein X designates a pharmaceutically active peptide sequence, e.g. Leu-enkephalin; Z designates a peptide pre-sequence of 2 to 20 amino acid units, preferably comprising lysine and glutamic acid; and L is a linking group comprising from 3 to 9 backbone atoms, wherein the bond between the C-terminal carbonyl of X and L is different from a C-N amide bond. Preferably, the bond between X and L is an ester bond. It has been found that it is possible to obtain a remarkable increase in the resistance towards degradation by proteolytic enzymes such as carboxypeptidase A, pepsin A, leucine aminopeptidase, 'alpha'-chymotrypsin when masking a pharmaceutically active peptide as a prodrug of the formula (I). The prodrugs of formula (I) are cleaved by the blood plasma enzyme butyryl cholinesterase indicating a readily bioreversibility. It is believed that the stability towards enzymatic cleavage is due to an induced helix-like structure.
Patent NZ-501249-A (NZ)
Title: Delayed-release (pH or enzymatically triggered) dosage forms of sertraline
Inventor: CURATOLO WILLIAM JOHN
IPC: A61K9/28
Filed: 1998-06-16
Abstract: Sertraline is a selective serotonin reuptake inhibitor (SSRI), which is useful as an antidepressant and anorectic agent, and in the treatment of obsessive-compulsive disorder, post-traumatic stress disorder, anxiety-related disorders and panic. Delayed-release dosage forms of sertraline, which reduce Tmax and side effects, are described. The dosage forms are, in general, spatially delayed by being sensitive to their position along the gastrointestinal tract, or temporally delayed by being delayed for a preset period, independent of their position along the gastrointestinal tract. In vitro tests for identifying such dosage forms are presented.
Patent NZ-501643-A (NZ)
Title: Apparatus for injection moulding of large plastic components with extruder, accumulator and mould valve with pressure sensed in mould
Inventor: SMORGON VICTOR
IPC: B29C45/53
Filed: 1998-05-20
Abstract: A system for injection moulding of large plastics components in a single shot comprises an extruder and an accumulator fed from the extruder. The accumulator leads into the mould (14) via a mould valve (12) operative, when closed, to close the mould cavity substantially at the mould surface and also to close an outlet (20a) from the accumulator. The valve passage of the mould valve is of relatively large cross section, typically several centimeters or more which facilitates injection at relatively low pressures and also facilitates passage of stones and other particulate matter which may be present if the extrudate is composed of post-consumer recycled plastics.
Patent NZ-504510-A (NZ)
Title: Methods and compositions for increasing efficiency of excision of a viral replicon from T-DNA that is transferred to a plant by agroinfection
Inventor: LYZNIK LESZEK ALEXANDER
IPC: C12N15/84
Filed: 1998-11-16
Abstract: Described are methods and compositions for site-specific recombinase-mediated mobilisation of viral replicons and associated DNAs of interest from T-DNA.  The methods comprise Agrobacterium-mediated transfer recombinase.  The nucleic acids may additionally contain expression cassettes encoding the cognate site-specific recombinase for the target sites flanking the viral genome.  The compositions further comprise Agrobacterium containing the nucleic acids of interest.  The compositions and methods have use in increasing the efficiency of agroinfection, providing high copy numbers of a DNA of interest for transient expression or for integration into a plant chromosome, and in simplifying the construction and stable maintenance of vectors for agroinfection and transformation.
Patent NZ-505406-A (NZ)
Title: Processes and intermediates useful to make antifolates
Inventor: KOBIERSKI MICHAEL EDWARD
IPC: A61K31/519
Filed: 1999-01-27
Abstract: Intermediates, and processes directed to and from those intermediates, to a series of pyrimidine derivatives of formula (V), which are intermediates to useful antifolate compounds or are themselves useful antifolate compounds.
Patent NZ-506731-A (NZ)
Title: Acoustic device relying on bending wave action
Inventor: AZIMA HENRY
IPC: H04R7/06
Filed: 1999-03-30
Abstract: Acoustic device comprising a member relying on bending wave action with beneficial distribution of resonant modes thereof, wherein the member has its acoustically active area at least partly bounded by means having a substantially restraining nature in relation to bending wave vibration. Operation can be below coincidence, or above if desired for active acoustic device further having beneficial location of bending wave transducer means determined with reference to and taking account of such bounding means.
Patent NZ-507704-A (NZ)
Title: Method, apparatus and system for filling containers
Inventor: BRENNAN JOHN
IPC: B67C3/02
Filed: 1999-04-21
Abstract: A filling apparatus for, a filling system for and a method of introducing into a container a suspension or solution of a substance, in particular a pharmaceutical substance, in a propellant under pressure is disclosed, wherein the filling apparatus comprises: a main body (4) including a passageway (20) having an inlet opening (21) and first and second outlet openings (25, 22), the first outlet opening (25) communicating, in use, with a valve stem (144) extending from a head (141) of a body (139) of a container (138); a fill actuator (7) in communication with the inlet opening (21) of the passageway (20) comprising a filling valve assembly (29) for selectively introducing propellant under pressure containing a substance in a suspension or solution into the passageway (20); an exhaust actuator (10) in communication with the second outlet opening (22) of the passageway (20) comprising an exhaust valve assembly (48) for selectively exhausting propellant under pressure containing substance from the passageway (20) and including at least one exhaust gas conduit (84, 92, 93) having an outlet (86, 94, 95) configured so as, in use, to provide a flow of exhaust gas substantially aligned with a flow of propellant containing substance from the second outlet opening (22) of the passageway (20); and a container-engaging body (16) for receiving, in use, the head (141) of the body (139) of the container (138) which includes the valve stem (144).
Patent NZ-508995-A (NZ)
Title: High-throughput screening of gene function using libraries of plasmids in a multi-well format for functional genomics applications
Inventor: VAN ES HELMUTH
IPC: A61K48/00
Filed: 1999-06-11
Abstract: A library of a multitude of unique expressible nucleic acids comprises a multiplicity of compartments. Each of the compartments comprises one or more adenoviral vectors comprising at lest one unique expressible nucleic acid of the library in an aqueous medium. The adenoviral vector is capable of introducing the unique expressible nucleic acid into a host cell, capable of expressing the product of the unique expressible nucleic acid into the host cell and is deleted in a portion of the adenoviral genome necessary for replication thereof in the host cell. Also described is a method for producing a library comprising of a multitude of unique expressible nucleic acids arranged in a multiplicity of compartments, a method of producing a recombinant adenovirus vector library and a method for measuring the function of a unique expressible nucleic acid(s) of unknown function in a high throughput setting.
Patent NZ-509316-A (NZ)
Title: Product and method for improving avian health
Inventor: HENRY CRAIG W
IPC: A01M29/12
Filed: 1999-07-07
Abstract: A composition comprising a substrate within an avian house and a non-toxic polycyclic quinone compound applied to the substrate, wherein the substrate comprises flooring, walls or litter, with the effect that ingestion of the substrate by the avian is reduced.
Patent NZ-511053-A (NZ)
Title: Modular high pressure electrolyser module
Inventor: VANDENBORRE JAN-BAPTIST HUGO
IPC: C25B9/19
Filed: 1999-10-08
Abstract: A high pressure electrolyser having a number of electrolysis chambers being held in frame 1, separated by membrane 2 to which the electrodes 3 are pressed. The electrodes are electrically connected to the bipolar plate 4 with a metal woven sheet 5. The frame has the larger conduit openings 7 on the top side and 8 on the bottom side. Conduit openings 7 evacuate the gas that is generated and openings 8 form a supply channel of electrolyte. Opening 7 is connected to the electrolyser module's inner space with the small connecting conduit 9 and similarly, opening 8 is connected to the inner space via small connecting conduit 10. A ring shaped frame having conduit openings for the supply of electrolyte and the removal of the gasses that are generated and further having a connecting surface with concentric elevations and depressions.
Patent NZ-511211-A (NZ)
Title: Carcass management
Inventor: PHILLIPS DOUGLAS MORELAND
IPC: A22B5/16
Filed: 2001-04-19
Abstract: An apparatus (1) for removing the pelt from an animal carcass includes a first securing means (2) capable of retaining a predetermined portion of the carcass. There is also a second securing means capable of retaining a partially detached portion of pelt between at least two substantially opposed clamping surfaces (3). In addition, a detector (12) is made present, where the detector is made to detect the presence of at least one of the clamping surface at a certain position. Once detection is made, a triggering means is made to activate the second securing means to secure the detached portion of pelt. Upon activation of the second securing means, a displacement means (4) effects the relative movement between the first and second securing means.
Patent NZ-512664-A (NZ)
Title: Use of growth hormone secretagogues for stimulating or increasing appetite
Inventor: PAN LYDIA CODETTA
IPC: A61K31/437
Filed: 2001-06-28
Abstract: Described is the use of compounds of formula (I) in the manufacture of a medicament for stimulating or increasing appetite in a patient, wherein HET is a heterocyclic moiety selected from the group consisting of formula (II) -formula (VI), and the remaining substituents are defined in the specification.  The medicament may also include a recombinant growth hormone or a growth hormone secretagogue, an antidepressant or an antipsychotic agent.
Patent NZ-516323-A (NZ)
Title: Tie down device and method of use
Inventor: COMBES BRIAN H
IPC: E04H15/64
Filed: 2000-06-16
Abstract: A tie down device for sheet material such as tarpaulin (12) and the like is disclosed.  The device includes a bar (14) and a sleeve (17).  The sleeve (17) has a slit extending from end to end thereof for receiving the bar (14) as well as sheet material which extends around the bar (14) and outwardly through the slit of the sleeve (17) on opposite sides of the bar (14).  In addition, a rope (19) is secured to the bar (14) which extends through the slit when the bar (14) is received in the sleeve (17).  The rope (19) enables the device to be placed under tension so that the bar (14) binds the sheet material extending around the bar (14) against the sleeve (17).  This binding action firmly secures the sheet material to the device and thereby prevents the sheet material from slipping out of the device between the bar (14) and sleeve (17).
Patent NZ-520800-A (NZ)
Title: Humanised monoclonal antibodies that sequester amyloid beta peptide so as to prevent its deposition in the brain
Inventor: HOLTZMAN DAVID M
IPC: A61K/
Filed: 2001-02-26
Abstract: A method to treat conditions characterized by formation of amyloid plaques both prophylactically and therapeutically is described. The method employs humanized antibodies which sequester soluble A beta peptide from human biological fluids or which preferably bind specifically to an epitope contained within position 13-28 of the amyloid beta peptide Aâ.
Patent NZ-522126-A (NZ)
Title: Two way cable system with noise-free return path
Inventor: LAKHANI ABDUL-KARIM
IPC: H04N7/173
Filed: 2001-03-30
Abstract: The return path for a signal in a cable system uses a portion of the 50-750 MHz frequency band to send signals from each set-top box therein to a receiver at the feeder line end. A band stop filter is placed in each auxiliary feeder line to prevent the return signal from set-top boxes being received by more than one feeder line end. The feeder line end also has a receiver and high to low frequency converter that retransmits the signals in the low portion (5-50 MHz of the frequency spectrum) to the headend. High pass filters are placed at taps going into homes to prevent low frequency noise from home devices, home wiring and drop wiring from entering the feeder lines. This system eliminates virtually all ingress noise picked up by the collection of set-top boxes, home wiring and drop wiring from entering the cable system.
Patent NZ-523131-A (NZ)
Title: Transcutaneous prosthesis
Inventor: BLUNN GORDON
IPC: A61F2/54
Filed: 2001-06-22
Abstract: A transcutaneous prosthesis is disclosed comprising a first component (1) shaped for implantation into a bone (2), a second component (4) intended for location between the bone and the skin, and a third component (5) intended for location exterior to the skin surface, having a low surface energy which deters bacterial adhesion. The second component may carry an adhesion-promoting protein.